Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

Steele Resources Starts Drilling at Mineral Hill Gold Mine

Molycorp Receives Authorization to Begin Exploratory Drilling at Heavy Rare Earth, California

NV Gold Completes Switzerland Gold Exploration Campaign in Switzerland

Crazy Horse Resources Announces Assay Results from Taysan Project

Messina Minerals Discovers Outcropping Sulphide Mineralization at Brook Prospect

Camino Minerals Receives Final Assay Results from Rodeo Gold Project

Mining Will Continue to Drive Australian Economy in 2012

Western Lithium Completes Pre-Feasibility Study in Nevada

Mining Now Employing 100,000 People in WA

Mutiny Gold Acquires Gullewa Gold Project in Full

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.